Recruiting
Phase 2

Daratumumab

Sponsor:

Mayo Clinic

Code:

NCT05898646

Conditions

AL Amyloidosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Marrow Aspiration

Daratumumab

Echocardiography

Questionnaire Administration

X-Ray Imaging

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-04-24.